Skip to main content
. 2021 Aug 6;99:108049. doi: 10.1016/j.intimp.2021.108049

Table 5.

Clinical trial data on complement system inhibitors in COVID-19.

Drug Under Investigation Aim of The Trial. Status of Clinical Trial Location Results from The Trial References
Eculizumab To assess whether by modulating the activity of immune response with Eculizumab, can mortality be halted while the patient has time to recover from the virus with supportive medical care. Recruiting United States, France No results posted [103]